Drug Repurposing for the Treatment of Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a heterogeneous disease characterized by the accumulation of immature myeloid progenitor cells in the bone marrow, compromising of normal blood cell production and ultimately resulting in bone marrow failure. With a 20% overall survival rate at 5 years and 50% in the...
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Frontiers Media S.A.
2017-11-01
|
| Schriftenreihe: | Frontiers in Medicine |
| Schlagworte: | |
| Online-Zugang: | http://journal.frontiersin.org/article/10.3389/fmed.2017.00211/full |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|